1. New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
   Chien-shan Cheng et al, 2019, Cancer Cell International CrossRef
2. Bufalin serves as a pharmaceutic that mitigates drug resistance
   Linxuan Miao et al, 2023, Drug Metabolism Reviews CrossRef
3. In silico analysis of the potential mechanism of telocinobufagin on breast cancer MCF-7 cells
   Yi-wu Dang et al, 2018, Pathology - Research and Practice CrossRef
4. Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression
   Jie Wang et al, 2018, Oncotarget CrossRef
5. Bufalin: A Systematic Review of Research Hotspots and Antitumor Mechanisms by Text Mining and Bioinformatics
   Xian Zhang et al, 2020, The American Journal of Chinese Medicine CrossRef
6. Iron oxide-alginate-berbamine nanocomposites trigger reactive oxygen species-induced apoptosis through down-regulation of PI3K/AKT signaling in human bladder cancer cells
   Huajun Zhang et al, 2022, Process Biochemistry CrossRef
7. Bufalin for an innovative therapeutic approach against cancer
   Laura Soumoy et al, 2022, Pharmacological Research CrossRef
8. Bufalin induced apoptosis of bladder carcinoma cells through the inactivation of Na+K+‑ATPase
   Huang Houbao et al, 2018, Oncology Letters CrossRef
9. A research update on the antitumor effects of active components of Chinese medicine ChanSu
   Jinhao Jia et al, 2022, Frontiers in Oncology CrossRef
10. Bufalin Suppresses Colorectal Cancer Cells by the Blockade of Canonical Wnt Signaling Pathway
    Wanmi Sui et al, 2022, 2022 4th International Conference on Intelligent Medicine and Image Processing CrossRef
11. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
    Qingmei Ye et al, 2023, Frontiers in Pharmacology CrossRef
12. Proscillaridin A Sensitizes Human Colon Cancer Cells to TRAIL-Induced Cell Death
    Manami Semba et al, 2022, International Journal of Molecular Sciences CrossRef
13. Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway
    Jincheng Song et al, 2021, Carcinogenesis CrossRef
14. Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment
    Li-Juan Deng et al, 2020, European Journal of Pharmacology CrossRef
15. Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK/STAT, Wnt/β-Catenin, mTOR, TRAIL/TRAIL-R, and Non-Coding RNAs
    Ammad Ahmad Farooqi et al, 2023, Molecules CrossRef
16. TRAIL-mediated signaling in bladder cancer: realization of clinical efficacy of TRAIL-based therapeutics in medical oncology
    Ammad Ahmad Farooqi et al, 2023, Medical Oncology CrossRef